Join Our Community at pep4life.substack.com All Rights Reserved, Pep 4 Life LLC, 2026 5220 US Hwy 1, Unit 104-355, Vero Beach, FL 32967 (800) 894-2167 All products on this site are for research purposes only
Sources Tirzepatide Once Weekly for the Treatment of Obesity (June 4, 2022) Fda Clarifies Policies For Compounders As National Glp-1 Supply Begins To Stabilize (April 28, 2025) Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea: The PIONEER 3 Randomized Clinical Trial (March 23, 2019) Lilly's Zepbound (Tirzepatide) Superior To Wegovy (Semaglutide) In Head-To-Head Trial Showing An Average Weight Loss Of 20.2% Vs
GIP (Glucose-Dependent Insulinotropic Polypeptide): Works synergistically with GLP-1
This is why your honest and accurate communication is so important during the screening process
Furthermore, it is apparent that the dismissal of the study due to bias is unwarranted and not supported by any available information
